As of 2024-12-14, the Intrinsic Value of Collegium Pharmaceutical Inc (COLL) is
16.78 USD. This COLL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 30.09 USD, the upside of Collegium Pharmaceutical Inc is
-44.20%.
The range of the Intrinsic Value is (2.97) - 420.65 USD
16.78 USD
Intrinsic Value
COLL Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(2.97) - 420.65 |
16.78 |
-44.2% |
| DCF (Growth 10y) |
2.44 - 534.90 |
27.58 |
-8.3% |
| DCF (EBITDA 5y) |
69.99 - 169.71 |
106.00 |
252.3% |
| DCF (EBITDA 10y) |
39.89 - 201.12 |
89.33 |
196.9% |
| Fair Value |
68.68 - 68.68 |
68.68 |
128.24% |
| P/E |
69.87 - 84.50 |
77.23 |
156.7% |
| EV/EBITDA |
145.84 - 381.22 |
199.54 |
563.1% |
| EPV |
(29.73) - (40.30) |
(35.02) |
-216.4% |
| DDM - Stable |
33.01 - 213.77 |
123.39 |
310.1% |
| DDM - Multi |
50.75 - 257.50 |
85.00 |
182.5% |
COLL Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
970.40 |
| Beta |
0.39 |
| Outstanding shares (mil) |
32.25 |
| Enterprise Value (mil) |
1,798.65 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.49% |
| Cost of Debt |
28.48% |
| WACC |
13.60% |